Via San Diego Source:
Caremark Rx Inc. (NYSE: CMX) led off another flurry of earnings reports with a 20 percent jump in second quarter profits. The pharmaceutical service provider also increased its full-year forecasts. Caremark added $1.05 to $55.69.
Yippee, Caremark. I, on the other hand, have suffered a loss of $1,107 through the second quarter of 2006 because of their refusal to cover Sticks’ meds. That’s a LOSS to help their PROFITS.
I wonder how many other subscribers are losing money so they can make money. Speak up in the comments if you’re one.
Technorati Tags: caremark, profits, PBM
Sphere: Related Content


